1-9 of 9
Verena Passerini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Johannes Adrian Hildebrand, Sarah Haebe, Verena Passerini, Michael Heide, William Keay, Louisa Adolph, Lukas Ulrich, Natyra Tahiri, Raphael Koch, Jessica Duffy, Haley Martin, Liam Hackett, Jeremy Zhang, Christina Ludwig, Stefanie Wilhelm, Björn Häupl, Carmen Doebele, Michael von Bergwelt-Baildon, Axel Lechner, Tobias Herold, Christian Kellner, Martina Rudelius, Thomas Oellerich, Marc Schmidt-Supprian, Abner Louissaint, Matthew S Davids, Oliver Weigert
Journal: Blood
Blood (2023) 142 (Supplement 1): 4358.
https://doi.org/10.1182/blood-2023-174384
Published: 2023
Journal Articles

An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial

Verena Passerini, Vindi Jurinovic, Christopher R Bolen, Andrea Knapp, Alessia Bottos, Julia Richter, Jude Fitzgibbon, Wolfram Klapper, Andrew Davies, Robert Marcus, Michael von Bergwelt, Tina Nielsen, Martin H. Dreyling, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Oliver Weigert
Journal: Blood
Blood (2021) 138 (Supplement 1): 39.
https://doi.org/10.1182/blood-2021-147751
Published: 2021
Journal Articles

ARID1A Controls a Novel Transcriptional Network Regulating FAS in Follicular Lymphoma

Martina Antoniolli, Maria Solovey, Deepak Bararia, Carolin Dorothea Strobl, William David Keay, Johannes Adrian Hildebrand, Michael Heide, Verena Passerini, Lucas Wange, Wolfgang Enard, Susanne Thieme, Helmut Blum, Martina Rudelius, Sebastian Bultmann, Heinrich Leonhardt, Marion Subklewe, Michael von Bergwelt, Maria Colomé-Tatché, Oliver Weigert
Journal: Blood
Blood (2021) 138 (Supplement 1): 3492.
https://doi.org/10.1182/blood-2021-148862
Published: 2021
Journal Articles

CHOP but Not Bendamustine Reverses EZH2 Y641 Mutation Induced MHC-I/II Loss in Human Lymphoma Models

Louisa Catharina Adolph, Quentin Fichaux, Carolin Dorothea Strobl, Martina Antoniolli, Verena Passerini, William David Keay, Vindi Jurinovic, Axel Lechner, Daniel J. Hodson, Michael von Bergwelt, Marion Subklewe, Martina Rudelius, Oliver Weigert
Journal: Blood
Blood (2021) 138 (Supplement 1): 2391.
https://doi.org/10.1182/blood-2021-144803
Published: 2021
Journal Articles

Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy

Vindi Jurinovic, PhD, Verena Passerini, PhD, Mikkel Z Oestergaard, PhD, Andrea Knapp, PhD, Kirsten Mundt, PhD, Shamzah Araf, MRCP, MBBS, PhD, Julia Richter, PhD, Jude Fitzgibbon, PhD, Wolfram Klapper, Robert E. Marcus, FRCP, Andrew Davies, MD PhD, Michael Herold, MD, Wolfgang Hiddemann, PhD, Michael Unterhalt, PhD, Eva Hoster, PhD, Oliver Weigert, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 122.
https://doi.org/10.1182/blood-2019-130208
Published: 2019
Journal Articles

Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma

Johannes Adrian Hildebrand, MSc, BSc, Deepak Bararia, Sebastian Stolz, Sarah Haebe, MD, Stefan Alig, Michael Bartoschek, Michael Boesl, Alessandro Pastore, Erik Gaitzsch, Michael Heide, Vindi Jurinovic, MSc, Monika Szczepanowski, Wolfram Klapper, Abner Louissaint, Jr., MD PhD, Christina Ludwig, Sebastian Bultmann, Heinrich Leonhardt, Sebastian Eustermann, Karl-Peter Hopfner, Wolfgang Hiddemann, MD PhD, Michael von Bergwelt, Christian Steidl, MD, Robert Kridel, MDMPH,PhD, David M Weinstock, Marc Schmidt-Supprian, Menyhárt B Sárosi, Verena Passerini, Josef Mautner, Oliver Weigert
Journal: Blood
Blood (2019) 134 (Supplement_1): 657.
https://doi.org/10.1182/blood-2019-122663
Published: 2019
Journal Articles

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016

Clinical Trials & Observations
Xiaoyu Qu, Hongli Li, Rita M. Braziel, Verena Passerini, Lisa M. Rimsza, Eric D. Hsi, John P. Leonard, Sonali M. Smith, Robert Kridel, Oliver Press, Oliver Weigert, Michael LeBlanc, Jonathan W. Friedberg, Min Fang
Journal: Blood
Blood (2019) 133 (1): 81–93.
https://doi.org/10.1182/blood-2018-07-865428
Published: 2019
Includes: Supplemental data
Journal Articles

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial

Stefan Alig, MD, Alessandro Pastore, Vindi Jurinovic, Sarah Häbe, Deepak Bararia, PhD, Verena Passerini, PhD, William Keay, Johannes Hellmuth, Andreas Rosenwald, Wolfram Klapper, MD, Harald Stein, MD PhD Dr. h.c., Alfred Feller, German Ott, MD, Annette M. Staiger, PhD, Heike Horn, Martin-Leo Hansmann, Christiane Pott, Roswitha Forstpointner, Wolf-Karsten Hofmann, Norbert Schmitz, MD, Georg Hess, Michael Unterhalt, Martin H. Dreyling, MD PhD, Anna-Katharina Zoellner, Christian Schmidt, MD, Eva Hoster, Wolfgang Hiddemann, Oliver Weigert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4096.
https://doi.org/10.1182/blood-2018-99-118000
Published: 2018
Journal Articles

PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma

Verena Passerini, PhD, Michael Boesl, Elisabeth Silkenstedt, MD, Elisa Osterode, Michael Heide, Robert Kridel, PhD MD, Christoph Ziegenhain, Annette M. Staiger, PhD, German Ott, MD, Monika Szczepanowski, PhD, Julia Richter, PhD, Wolfram Klapper, MD, Andreas Rosenwald, Wolfgang Enard, PhD, Wolfgang Hiddemann, Deepak Bararia, PhD, Zimber-Strobl Ursula, Dr., Oliver Weigert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2842.
https://doi.org/10.1182/blood-2018-99-118063
Published: 2018